The clinical trial of an old antibiotic for a new purpose is offering hope to thousands of patients with drug-resistant breast cancer whose early remissions have given way to resurgent tumors.
Mar 15, 2022
0
3
Acral melanoma is a rare subtype that represents roughly 3% of all melanoma cases. Unlike typical melanoma that occurs on sun-exposed skin, acral melanoma develops on the nonhair bearing skin of the soles, palm and nail beds. ...
Mar 11, 2022
0
68
The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—today announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Ampullary Adenocarcinoma. ...
Mar 9, 2022
0
2
A new study adds to a growing body of evidence that organoids—lab-grown collections of cells that mimic a patient's tumor—are a promising avenue for drug discovery to improve outcomes in patients with cancer, particularly ...
Feb 16, 2022
0
27
A group of researchers at Qatar Foundation led by Dr. Lotfi Chouchane from Weill Cornell Medicine—Qatar (WCM-Q) have reported the first landscape of cancer germline variation in the Middle East that has been published online ...
Feb 10, 2022
0
3
A revolutionary new way of caring for people with neuroendocrine tumors (NETs) will be trialed in the coming months, with the Flinders University-led project aiming to improve patient quality of life and develop a cost-effective ...
Jan 10, 2022
0
2
Pancreatic cancer forms in the cells of the pancreas, an organ in the abdomen that releases enzymes that aid digestion and produces hormones that help manage our blood sugar levels. Pancreatic cancer is a rare disease with ...
Nov 11, 2021
0
1
By combining computational and experimental approaches, University of Pittsburgh School of Medicine and Prairie View A&M University researchers identified cancer drugs that show promise for treating pulmonary hypertension, ...
Oct 20, 2021
0
22
Genetic testing of the siblings of newborns found to have mutations in any one of 11 genes most commonly associated with childhood-onset cancers could reduce deaths from these rare cancers by about 50%, suggests a study funded ...
Oct 19, 2021
0
0
The first randomized study in malignant pheochromocytoma and paraganglioma (MPP) has found that sunitinib prolongs progression-free survival (PFS) by more than five months. The late breaking results of the FIRSTMAPPP trial ...
Sep 20, 2021
0
15
